Compartmentalized Cyclic AMP Production by the Bordetella pertussis and Bacillus anthracis Adenylate Cyclase Toxins Differentially Affects the Immune Synapse in T Lymphocytes

Frontiers in Immunology
Vijay Bharathi ArumughamCosima T Baldari

Abstract

A central feature of the immune synapse (IS) is the tight compartmentalization of membrane receptors and signaling mediators that is functional for its ability to coordinate T cell activation. Second messengers centrally implicated in this process, such as Ca2+ and diacyl glycerol, also undergo compartmentalization at the IS. Current evidence suggests a more complex scenario for cyclic AMP (cAMP), which acts both as positive and as negative regulator of T-cell antigen receptor (TCR) signaling and which, as such, must be subjected to a tight spatiotemporal control to allow for signaling at the IS. Here, we have used two bacterial adenylate cyclase toxins that produce cAMP at different subcellular localizations as the result of their distinct routes of cell invasion, namely Bordetella pertussis CyaA and Bacillus anthracis edema toxin (ET), to address the ability of the T cell to confine cAMP to the site of production and to address the impact of compartmentalized cAMP production on IS assembly and function. We show that CyaA, which produces cAMP close to the synaptic membrane, affects IS stability by modulating not only the distribution of LFA-1 and its partners talin and L-plastin, as previously partly reported but also by promo...Continue Reading

References

Oct 16, 2001·American Journal of Physiology. Cell Physiology·C A HirshmanC W Emala
Jan 5, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katsuhiko ItohTakashi Saito
Jul 4, 2003·The Journal of Biological Chemistry·Rihong ZhouXuebiao Yao
Dec 31, 2003·Biochemical and Biophysical Research Communications·Fiorella TonelloCesare Montecucco
Oct 8, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hilde AbrahamsenKjetil Taskén
Feb 9, 2005·The Journal of Experimental Medicine·Silvia Rossi PaccaniCosima T Baldari
Jul 13, 2005·The Journal of Cell Biology·Joseph LinAndrey S Shaw
Oct 28, 2005·The American Journal of Pathology·Aaron M FirovedStephen H Leppla
Nov 4, 2006·The EMBO Journal·Federica Dal MolinCesare Montecucco
Nov 8, 2006·Cellular Microbiology·Silvia Rossi PaccaniCosima T Baldari
Jun 27, 2007·Molecular and Cellular Biology·Jeffrey C NolzDaniel D Billadeau
Oct 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anja RuppeltKjetil Taskén
Apr 23, 2008·Infection and Immunity·Silvia Rossi PaccaniCosima T Baldari
Sep 17, 2008·Biochemical and Biophysical Research Communications·Federica Dal MolinCesare Montecucco
Jan 7, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Meredith H ShafferJanis K Burkhardt
Jan 10, 2009·Annual Review of Immunology·Jennifer E Smith-GarvinMartha S Jordan
Jan 27, 2009·Current Opinion in Microbiology·Joanne Engel, Priya Balachandran
Jun 30, 2009·Molecular Aspects of Medicine·Jean-Nicolas TournierCosima T Baldari
Nov 16, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chen WangEric J Brown
Dec 7, 2010·Cellular Signalling·Randi Mosenden, Kjetil Taskén
Feb 12, 2011·The Journal of Allergy and Clinical Immunology·Silvia Rossi PaccaniCosima T Baldari
May 18, 2011·The Journal of Experimental Medicine·Silvia Rossi PaccaniCosima T Baldari
Jun 23, 2011·Handbook of Experimental Pharmacology·Elisa BjørgoKjetil Taskén
Aug 23, 2011·Scandinavian Journal of Immunology·R MosendenK Taskén
Nov 10, 2011·Toxins·Silvia Rossi Paccani, Cosima T Baldari
May 18, 2013·Biochimica Et Biophysica Acta·Sudha KumariMichael L Dustin
Nov 6, 2013·The Journal of Experimental Medicine·Audrey Le Floc'hMorgan Huse
Apr 2, 2014·Trends in Microbiology·Shihui LiuStephen H Leppla
Jul 20, 2014·Biochimica Et Biophysica Acta·Kohichi KawaharaYukihiko Sugimoto
Oct 31, 2014·Cellular and Molecular Life Sciences : CMLS·Audrey Le Floc'h, Morgan Huse
Nov 5, 2014·Cancer Immunology Research·Michael L Dustin

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
FCS
flow cytometry
FACS
confocal microscopy

Software Mentioned

Excel
GraphPad Prism
ImageJ
JACoP
Zen

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.